SMU Reseachers Find New Compounds May Inhibit Protein Responsible for Chemotherapy Resistance

SMU researchers have discovered three new drug-like compounds that could ultimately offer better odds of survival to prostate cancer patients. The drug-like compounds can be modified and developed into medicines that target a protein in the human body that is responsible for chemotherapy resistance in cancers, says Pia D. Vogel, professor of biochemistry at SMU and lead author on the scientific paper reporting the discovery.